Cargando…

Serum interleukin-38 levels correlated with insulin resistance, liver injury and lipids in non-alcoholic fatty liver disease

BACKGROUND: Insulin resistance, liver injury and dyslipidemia are reported in non-alcoholic fat liver disease (NAFLD) patients. Interleukin (IL)-38 may take part in the pathophysiology of insulin resistance. Nevertheless, the function of IL-38 in NAFLD is unknown. Herein, we determined whether serum...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cao, Jun, Hua, Lin, Zhang, Shipei, Tang, Jinping, Ke, Fan, Wu, Zhouhuan, Xue, Guohui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364532/ https://www.ncbi.nlm.nih.gov/pubmed/35948957 http://dx.doi.org/10.1186/s12944-022-01676-0

Ejemplares similares

Prediction of non-alcoholic fatty-liver disease and liver fat content by serum molecular lipids
por: Orešič, Matej, et al.
Publicado: (2013)

The Correlation Between Serum Adipokines and Liver Cell Damage in Non-Alcoholic Fatty Liver Disease
por: Jamali, Raika, et al.
Publicado: (2016)

Angiopoietin‐like protein 8/betatrophin correlates with hepatocellular lipid content independent of insulin resistance in non‐alcoholic fatty liver disease patients
por: Hong, Beverly S, et al.
Publicado: (2018)

Lipid droplet dynamics in alcoholic fatty liver disease
por: Schulze, Ryan J., et al.
Publicado: (2019)

The Relationship between Insulin Resistance and Liver Damage in non-alcoholic Fatty Liver Patients
por: Cetin, Elif Guven, et al.
Publicado: (2020)

Decrease in fasting insulin secretory function correlates with significant liver fibrosis in Japanese non‐alcoholic fatty liver disease patients
por: Araki, Norimasa, et al.
Publicado: (2020)

Mechanism of CD38 via NAD(+) in the Development of Non-alcoholic Fatty Liver Disease
por: Dong, Min, et al.
Publicado: (2023)

Fatty liver biomarkers and insulin resistance indices in the prediction of non‐alcoholic fatty liver disease in Ghanaian patients
por: Bockarie, A. S., et al.
Publicado: (2023)

Homeostasis of Glucose and Lipid in Non-Alcoholic Fatty Liver Disease
por: Chao, Hsu-Wen, et al.
Publicado: (2019)

Hydrogen sulphide in liver glucose/lipid metabolism and non‐alcoholic fatty liver disease
por: Mateus, Inês, et al.
Publicado: (2021)

Interleukin‐32 Contributes to Human Nonalcoholic Fatty Liver Disease and Insulin Resistance
por: Dali‐Youcef, Nassim, et al.
Publicado: (2019)

Camel milk ameliorates steatohepatitis, insulin resistance and lipid peroxidation in experimental non-alcoholic fatty liver disease
por: Korish, Aida A, et al.
Publicado: (2013)

Non-alcoholic fatty liver disease and correlation of serum alanin aminotransferase level with histopathologic findings
por: Khosravi, Somaye, et al.
Publicado: (2011)

Role of thiazolidinediones, insulin sensitizers, in non‐alcoholic fatty liver disease
por: Chang, Eugene, et al.
Publicado: (2013)

Nutritional Modulation of Non-Alcoholic Fatty Liver Disease and Insulin Resistance
por: Yki-Järvinen, Hannele
Publicado: (2015)

Altered Fecal Microbiota Correlates with Liver Biochemistry in Nonobese Patients with Non-alcoholic Fatty Liver Disease
por: Wang, Baohong, et al.
Publicado: (2016)

Interleukin-34 as a fibroblast-derived marker of liver fibrosis in patients with non-alcoholic fatty liver disease
por: Shoji, Hirotaka, et al.
Publicado: (2016)

Correlation of Body Mass Index and Serum Parameters With Ultrasonographic Grade of Fatty Change in Non-alcoholic Fatty Liver Disease
por: Abangah, Ghobad, et al.
Publicado: (2014)

Serum Dipeptidyl Peptidase-4 Activity in Insulin Resistant Patients with Non-Alcoholic Fatty Liver Disease: A Novel Liver Disease Biomarker
por: Firneisz, Gábor, et al.
Publicado: (2010)

The Role of Lipid and Lipoprotein Metabolism in Non-Alcoholic Fatty Liver Disease
por: Perla, Francesco M., et al.
Publicado: (2017)

Serum autotaxin levels are correlated with hepatic fibrosis and ballooning in patients with non-alcoholic fatty liver disease
por: Fujimori, Naoyuki, et al.
Publicado: (2018)

Correlation between Serum Ferritin Level and Histopathological Disease Severity in Non-alcoholic Fatty Liver Disease
por: Modares Mousavi, Seyed Reza, et al.
Publicado: (2018)

Correlation between serum 25-OH vitamin D expression and non-alcoholic fatty liver disease
por: Cai, Jiayan, et al.
Publicado: (2020)

Effect and the probable mechanisms of silibinin in regulating insulin resistance in the liver of rats with non-alcoholic fatty liver
por: Yao, Jiayin, et al.
Publicado: (2013)

Autophagy in non-alcoholic fatty liver disease and alcoholic liver disease()
por: Khambu, Bilon, et al.
Publicado: (2018)

Hepcidin levels correlate to liver iron content, but not steatohepatitis, in non-alcoholic fatty liver disease
por: Marmur, Joel, et al.
Publicado: (2018)

Effects of Folic Acid Supplementation on Liver Enzymes, Lipid Profile, and Insulin Resistance in Patients with Non-Alcoholic Fatty Liver Disease: A Randomized Controlled Trial
por: Molaqanbari, Mohamad Reza, et al.
Publicado: (2023)

The effect of an aerobic exercise on serum level of liver enzymes and liver echogenicity in patients with non alcoholic fatty liver disease
por: Khaoshbaten, Manochehr, et al.
Publicado: (2013)

Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease
por: Ipsen, David Højland, et al.
Publicado: (2018)

Biomarkers and subtypes of deranged lipid metabolism in non-alcoholic fatty liver disease
por: Mato, José M, et al.
Publicado: (2019)

The association of lipid metabolism and non-alcoholic fatty liver disease in children with obesity
por: Hazer, İlhan, et al.
Publicado: (2020)

Qushi Huayu decoction ameliorates non-alcoholic fatty liver disease in rats by modulating gut microbiota and serum lipids
por: Ni, Yiming, et al.
Publicado: (2023)

Resveratrol Improves Liver Steatosis and Insulin Resistance in Non-alcoholic Fatty Liver Disease in Association With the Gut Microbiota
por: Du, Fan, et al.
Publicado: (2021)

Non-alcoholic fatty liver disease and liver secretome
por: Khan, Muhammad Sohaib, et al.
Publicado: (2022)

Role of Hepatokines in Non-alcoholic Fatty Liver Disease
por: Ke, Yini, et al.
Publicado: (2019)

Correlation of visfatin level with non-alcoholic fatty liver in metabolic syndrome
por: Mousavi, Zohreh, et al.
Publicado: (2017)

The association between non‐alcoholic fatty liver disease and serum ferritin levels in American adults
por: Yang, Naibin, et al.
Publicado: (2022)

Serum prohepcidin levels in chronic hepatitis C, alcoholic liver disease, and nonalcoholic fatty liver disease
por: Lee, Sang Hyub, et al.
Publicado: (2010)

Serum YKL-40 as a marker of liver fibrosis in patients with non-alcoholic fatty liver disease
por: Kumagai, Erina, et al.
Publicado: (2016)

Serum Malondialdehyde is Associated with Non-Alcoholic Fatty Liver and Related Liver Damage Differentially in Men and Women
por: Zelber-Sagi, Shira, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_sn6hp8a6alnsofj1kacbokc1b1